Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
Go back to Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer| CARA THERAPEUTICS (NASDAQ: CARA) | Delayed: 5.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.32 | 52 Week High | $17.69 | |||
| Open | $5.32 | 52 Week Low | $4.26 | |||
| Day High | $5.32 | P/E | N/A | |||
| Day Low | $5.32 | EPS | $-0.42 | |||
| Volume | 401 | |||||
| (NASDAQ: IOVA) | Delayed: 10.80 +0.61 (5.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.19 | 52 Week High | $ | |||
| Open | $10.40 | 52 Week Low | $ | |||
| Day High | $10.83 | P/E | N/A | |||
| Day Low | $10.15 | EPS | $ | |||
| Volume | 11,922,985 | |||||
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 47.89 -0.24 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.13 | 52 Week High | $4.38 | |||
| Open | $47.87 | 52 Week Low | $1.88 | |||
| Day High | $48.14 | P/E | N/A | |||
| Day Low | $47.00 | EPS | $-1.12 | |||
| Volume | 143,824 | |||||
